» Authors » Tom J Snijders

Tom J Snijders

Explore the profile of Tom J Snijders including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 946
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schilder M, Mandija S, Jacobs S, Kleinloog J, Liu H, van der Heide O, et al.
MAGMA . 2025 Mar; PMID: 40035911
Objective: To report T/T-values of normal and normal appearing brain tissues (NBTs, healthy volunteers; NABTs, patients) acquired with a whole-brain 5-minute Magnetic Resonance Spin TomogrAphy in Time-domain (MR-STAT) protocol, and...
2.
Pichler J, Traub-Weidinger T, Spiegl K, Imamovic L, Braat A, Snijders T, et al.
Neurooncol Adv . 2024 Aug; 6(1):vdae130. PMID: 39211520
Background: Glioblastoma (GBM), the most common malignant brain tumor, is associated with devastating outcomes. IPAX-1 was a multicenter, open-label, single-arm phase I study to evaluate carrier-added 4--[I]iodo-phenylalanine ([I]IPA) plus external...
3.
Ho V, Anten M, Garst A, Bos E, Snijders T, Eekers D, et al.
J Neurooncol . 2024 Aug; 170(1):41-52. PMID: 39207626
Purpose: Meningiomas classified as grade 2-3 according to the World Health Organisation (WHO) require combined surgery and in most cases radiotherapy (RT). Their initial management was evaluated using the Dutch...
4.
Ahmad S, Muhlebner A, Snijders T, de Leng W, Seute T, van Leeuwaarde R
Cancer . 2024 Jun; 130(20):3473-3479. PMID: 38824656
Background: Central nervous system hemangioblastomas are the most prevalent manifestation of von Hippel-Lindau (VHL) disease and remain the main cause of mortality. Surgical resection is the primary treatment strategy, but...
5.
Bakker A, Ixkes A, Venugopal H, Ries M, Lak N, de Vos F, et al.
Cancers (Basel) . 2024 Apr; 16(8). PMID: 38672658
The performance of minimally invasive molecular diagnostic tools in brain tumors, such as liquid biopsy, has so far been limited by the blood-brain barrier (BBB). The BBB hinders the release...
6.
van Lith S, Pruis I, Tolboom N, Snijders T, Henssen D, Laan M, et al.
J Nucl Med . 2023 Aug; 64(10):1526-1531. PMID: 37652540
Upregulation of prostate-specific membrane antigen (PSMA) in neovasculature has been described in glioblastoma multiforme (GBM), whereas vasculature in nonaffected brain shows hardly any expression of PSMA. It is unclear whether...
7.
van Opijnen M, de Vos F, Nabuurs R, Snijders T, Nandoe Tewarie R, Taal W, et al.
Neurooncol Pract . 2023 Jul; 10(4):360-369. PMID: 37457228
Background: Despite current best treatment options, a glioblastoma almost inevitably recurs after primary treatment. However, in the absence of clear evidence, current guidelines on recurrent glioblastoma are not well-defined. Re-resection...
8.
Ho V, Anten M, Garst A, Bos E, Snijders T, Eekers D, et al.
Eur J Neurol . 2023 Jul; 30(10):3244-3255. PMID: 37433563
Background And Purpose: Meningiomas are the most common primary tumours of the central nervous system. This study aimed to provide comprehensive nationwide estimates on the incidence, prevalence and prognostic impact...
9.
van der Boog A, Rados M, Akkermans A, Dankbaar J, Kizilates U, Snijders T, et al.
Neurosurgery . 2022 Sep; 92(1):125-136. PMID: 36135366
Background: Postoperative ischemia can lead to neurological deficits and is a known complication of glioma resection. There is inconsistency in documented incidence of ischemia after glioma resection, and the precise...
10.
Boele F, den Otter P, Reijneveld J, de Witt Hamer P, van Thuijl H, Lorenz L, et al.
Neuro Oncol . 2022 Jul; 25(2):351-364. PMID: 35908832
Background: While patients with diffuse low-grade glioma (LGG) often survive for years, there is a risk of tumor progression which may impact patients' long-term health-related quality of life (HRQOL) and...